Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug:216:A7-A8.
doi: 10.1016/j.ajo.2020.05.012. Epub 2020 May 25.

Is This a 737 Max Moment for Brolucizumab?

Philip J Rosenfeld  1 , David J Browning  2
Affiliations
Editorial

Is This a 737 Max Moment for Brolucizumab?

Philip J Rosenfeld et al. Am J Ophthalmol. 2020 Aug.
No abstract available

PubMed Disclaimer

Comment in

References

    1. Novartis provides update on use and safety of Beovu® in patients with wet AMD. https://www.novartis.com/news/novartis-provides-update-use-and-safety-be... Available at.
    1. American Society of Retina Specialists Research and Safety in Therapeutics Committee. 2020. https://www.asrs.org/about/committees/51 Available at.
    1. American Academy of Ophthalmology Audio Episode 227: the ASRS ReST Report on Brolucizumab. 2020. https://www.aao.org/audio/episode-227-asrs-rest-report-on-brolucizumab-with Available at.
    1. Nguyen Q.D., Das A., Do D.V. Brolucizumab: evolution through preclinical and clinical studies and the implications for the management of neovascular age-related macular degeneration. Ophthalmology. 2020 doi: 10.1016/j.ophtha.2019.12.031. - DOI - PubMed
    1. Ladas I.D., Karagiannis D.A., Rouvas A.A., Kotsolis A.I., Liotsou A., Vergados I. Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2,000 injections. Retina. 2009;29:313–318. - PubMed

Publication types

MeSH terms

Substances